argenx: Q3 2026 diluted EPS $7.80 versus $5.18 a year earlier
FROM THE WIRE · SEEKINGALPHA.COM
* argenx SE press release [https://seekingalpha.com/pr/20695615-argenx-reports-third-quarter-2026-financial-results-and-provides-business-update] (ARGX [https://seekingalpha.com/symbol/ARGX]): Q3 EPS $7.80 diluted, compared with $5.18 a year earlier. * Product net sales rose 53%…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishStrong product sales growth and higher profit versus last year are a positive signal for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Product net sales rose 53% to $1.72 billion.
- 02VYVGART global net sales were about $1.7 billion, up 54% year over year.
- 03Combined R&D and SG&A expenses are expected to total about $4 billion in 2026.
- 04Cash and current financial assets were $3.7 billion as of September 30, 2026.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets